Download PDF
Semin intervent Radiol 2010; 27(3): 285-295
DOI: 10.1055/s-0030-1261787
© Thieme Medical Publishers

Complications of Radiofrequency Ablation of Hepatic, Pulmonary, and Renal Neoplasms

Matthew J. Howenstein1 , Kent T. Sato1
  • 1Department of Radiology, Northwestern University, Chicago, Illinois
Further Information

Publication History

Publication Date:
20 August 2010 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Percutaneous thermal ablation has emerged as a viable technique for treatment of numerous solid organ malignancies. As the number of these procedures increases, so do the complications that are seen. Most common complications are generally related to bleeding from the target organ during or after the procedure and from thermal injury to adjacent structures. The nature of these injuries depends on the particular organ being treated, therefore it it best to categorize them this way. We will review the more common complications seen following the ablation of tumors in the liver, kidney, and lung, discuss the clinical presentation associated with each, and suggest precautions to help avoid them in the future. Understanding the potential risks associated with this procedure is critical for treatment planning and fundamental for performing these procedures safely.

KEYWORDS

Complication - radiofrequency - ablation - liver - tumor

REFERENCES

  • 1 Nahum Goldberg S, Dupuy D E. Image-guided radiofrequency tumor ablation: challenges and opportunities—part I.  J Vasc Interv Radiol. 2001;  12(9) 1021-1032
    CrossrefPubMedGoogle Scholar
  • 2 Dodd III G D, Soulen M C, Kane R A et al.. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.  Radiographics. 2000;  20(1) 9-27
    CrossrefPubMedGoogle Scholar
  • 3 Gazelle G S, Goldberg S N, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy.  Radiology. 2000;  217(3) 633-646
    CrossrefPubMedGoogle Scholar
  • 4 Goldberg S N, Grassi C J, Cardella J F Society of Interventional Radiology Technology Assessment Committee et al. Image-guided tumor ablation: standardization of terminology and reporting criteria.  J Vasc Interv Radiol. 2005;  16(6) 765-778
    CrossrefPubMedGoogle Scholar
  • 5 Sacks D, McClenny T E, Cardella J F, Lewis C A. Society of Interventional Radiology clinical practice guidelines.  J Vasc Interv Radiol. 2003;  14(9 Pt 2) S199-S202
    CrossrefPubMedGoogle Scholar
  • 6 Dupuy D E, Goldberg S N. Image-guided radiofrequency tumor ablation: challenges and opportunities—part II.  J Vasc Interv Radiol. 2001;  12(10) 1135-1148
    CrossrefPubMedGoogle Scholar
  • 7 Nemcek A A. Complications of radiofrequency ablation of neoplasms.  Semin Intervent Radiol. 2006;  23 177-187
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Livraghi T, Solbiati L, Meloni M F, Gazelle G S, Halpern E F, Goldberg S N. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.  Radiology. 2003;  226(2) 441-451
    CrossrefPubMedGoogle Scholar
  • 9 Choi H, Loyer E M, DuBrow R A et al.. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications.  Radiographics. 2001;  21(Spec No, Spec No) S41-S54
    CrossrefPubMedGoogle Scholar
  • 10 Rhim H, Yoon K H, Lee J M et al.. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings.  Radiographics. 2003;  23(1) 123-134 discussion 134-136
    CrossrefPubMedGoogle Scholar
  • 11 Rhim H, Dodd III G D, Chintapalli K N et al.. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications.  Radiographics. 2004;  24(1) 41-52
    CrossrefPubMedGoogle Scholar
  • 12 Akahane M, Koga H, Kato N et al.. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management.  Radiographics. 2005;  25(Suppl 1) S57-S68
    CrossrefPubMedGoogle Scholar
  • 13 de Baère T, Risse O, Kuoch V et al.. Adverse events during radiofrequency treatment of 582 hepatic tumors.  AJR Am J Roentgenol. 2003;  181(3) 695-700
    CrossrefPubMedGoogle Scholar
  • 14 Curley S A, Marra P, Beaty K et al.. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients.  Ann Surg. 2004;  239(4) 450-458
    CrossrefPubMedGoogle Scholar
  • 15 Choi D, Lim H K, Rhim H et al.. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series.  Eur Radiol. 2007;  17(3) 684-692
    CrossrefPubMedGoogle Scholar
  • 16 Wong S L, Mangu P B, Choti M A et al.. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.  J Clin Oncol. 2010;  28(3) 493-508
    CrossrefPubMedGoogle Scholar
  • 17 Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.  Eur Radiol. 2001;  11(6) 914-921
    CrossrefPubMedGoogle Scholar
  • 18 Cha J, Rhim H, Lee J Y et al.. Percutaneous radiofrequency ablation of hepatocellular carcinoma: assessment of safety in patients with ascites.  AJR Am J Roentgenol. 2009;  193(5) W424–W429
    PubMedGoogle Scholar
  • 19 Chen M H, Wei Y, Yan K et al.. Treatment strategy to optimize radiofrequency ablation for liver malignancies.  J Vasc Interv Radiol. 2006;  17(4) 671-683
    CrossrefPubMedGoogle Scholar
  • 20 Poon R T, Ng K K, Lam C M et al.. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution.  Ann Surg. 2004;  239(4) 441-449
    CrossrefPubMedGoogle Scholar
  • 21 Smith E H. Complications of percutaneous abdominal fine-needle biopsy. Review.  Radiology. 1991;  178(1) 253-258
    CrossrefPubMedGoogle Scholar
  • 22 Llovet J M, Vilana R, Brú C Barcelona Clínic Liver Cancer (BCLC) Group et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.  Hepatology. 2001;  33(5) 1124-1129
    CrossrefPubMedGoogle Scholar
  • 23 Uña E, Trueba J, Montes J M. Unexplained liver laceration after metastasis radiofrequency ablation.  World J Gastroenterol. 2009;  15(40) 5103-5105
    CrossrefPubMedGoogle Scholar
  • 24 Rao M P, Bell R. Pulmonary hemorrhage after radioablation of liver metastases.  Anesth Analg. 2003;  97(3) 684-686
    PubMedGoogle Scholar
  • 25 Kim Y S, Rhim H, Lim H K, Choi D, Lee W J, Kim S H. Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode.  J Vasc Interv Radiol. 2007;  18(9) 1126-1133
    CrossrefPubMedGoogle Scholar
  • 26 Shibata T, Yamamoto Y, Yamamoto N et al.. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors.  J Vasc Interv Radiol. 2003;  14(12) 1535-1542
    CrossrefPubMedGoogle Scholar
  • 27 Kim W, Clark T WI, Baum R A, Soulen M C. Risk factors for liver abscess formation after hepatic chemoembolization.  J Vasc Interv Radiol. 2001;  12(8) 965-968
    CrossrefPubMedGoogle Scholar
  • 28 Bessoud B, Doenz F, Qanadli S D, Nordback P, Schnyder P, Denys A. Enterobiliary fistula after radiofrequency ablation of liver metastases.  J Vasc Interv Radiol. 2003;  14(12) 1581-1584
    PubMedGoogle Scholar
  • 29 Kim Y S, Rhim H, Sung J H et al.. Bronchobiliary fistula after radiofrequency thermal ablation of hepatic tumor.  J Vasc Interv Radiol. 2005;  16(3) 407-410
    CrossrefPubMedGoogle Scholar
  • 30 Park B J, Byun J H, Jin Y H et al.. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.  J Vasc Interv Radiol. 2009;  20(4) 490-499
    CrossrefPubMedGoogle Scholar
  • 31 Shibata T, Shibata T, Maetani Y et al.. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.  J Vasc Interv Radiol. 2004;  15(11) 1323-1327
    PubMedGoogle Scholar
  • 32 Meloni M F, Goldberg S N, Moser V, Piazza G, Livraghi T. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma.  Eur J Ultrasound. 2002;  15(1-2) 73-76
    CrossrefPubMedGoogle Scholar
  • 33 Novellas S, Karimdjee B S, Caramella T, Benchimol D, Chevallier P. Perforation of a subhepatic retrocecal appendix after radiofrequency ablation of a hepatic metastasis.  J Vasc Interv Radiol. 2007;  18(10) 1334-1336
    CrossrefPubMedGoogle Scholar
  • 34 Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.  Br J Surg. 2005;  92(7) 856-858
    CrossrefPubMedGoogle Scholar
  • 35 Jaskolka J D, Asch M R, Kachura J R et al.. Needle tract seeding after radiofrequency ablation of hepatic tumors.  J Vasc Interv Radiol. 2005;  16(4) 485-491
    CrossrefPubMedGoogle Scholar
  • 36 Goldberg S N, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma.  Hepatology. 2001;  34(3) 609-611, author reply 610–611
    CrossrefPubMedGoogle Scholar
  • 37 Livraghi T. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma.  Hepatology. 2001;  34(3) 608-609, author reply 610–611
    CrossrefPubMedGoogle Scholar
  • 38 Espinoza S, Briggs P, Duret J S, Lapeyre M, de Baère T. Radiofrequency ablation of needle tract seeding in hepatocellular carcinoma.  J Vasc Interv Radiol. 2005;  16(5) 743-746
    CrossrefPubMedGoogle Scholar
  • 39 Steinke K, Gananadha S, King J, Zhao J, Morris D L. Dispersive pad site burns with modern radiofrequency ablation equipment.  Surg Laparosc Endosc Percutan Tech. 2003;  13(6) 366-371
    CrossrefPubMedGoogle Scholar
  • 40 Goldberg S N, Solbiati L, Halpern E F, Gazelle G S. Variables affecting proper system grounding for radiofrequency ablation in an animal model.  J Vasc Interv Radiol. 2000;  11(8) 1069-1075
    CrossrefPubMedGoogle Scholar
  • 41 Sawada M, Watanabe S, Tsuda H, Kano T. An increase in body temperature during radiofrequency ablation of liver tumors.  Anesth Analg. 2002;  94(6) 1416-1420
    CrossrefPubMedGoogle Scholar
  • 42 Goodman E J, Johnson P A. Radiofrequency ablation of hepatic tumors can cause elevation of the patient's temperature.  Anesth Analg. 2003;  97(4) 1203-1204
    PubMedGoogle Scholar
  • 43 Frich L, Halvorsen P S, Skulstad H, Damås J K, Gladhaug I P. Microbubbles in the pulmonary artery generated during experimental hepatic radiofrequency ablation is correlated with increased pulmonary arterial pressure.  J Vasc Interv Radiol. 2007;  18(3) 437-442
    CrossrefPubMedGoogle Scholar
  • 44 Sweesy M W, Holland J L, Smith K W. Electromagnetic interference in cardiac rhythm management devices.  AACN Clin Issues. 2004;  15(3) 391-403
    CrossrefPubMedGoogle Scholar
  • 45 Donohoo J H, Anderson M T, Mayo-Smith W W. Pacemaker reprogramming after radiofrequency ablation of a lung neoplasm.  AJR Am J Roentgenol. 2007;  189(4) 890-892
    CrossrefPubMedGoogle Scholar
  • 46 Tong N Y, Ru H J, Ling H Y, Cheung Y C, Meng L W, Chung P C. Extracardiac radiofrequency ablation interferes with pacemaker function but does not damage the device.  Anesthesiology. 2004;  100(4) 1041
    CrossrefPubMedGoogle Scholar
  • 47 Hayes D L, Charboneau J W, Lewis B D, Asirvatham S J, Dupuy D E, Lexvold N Y. Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers.  Mayo Clin Proc. 2001;  76(9) 950-952
    CrossrefPubMedGoogle Scholar
  • 48 Asensio E L, López T G, Guerrero M H et al.. Radiofrequency ablation of a hepatic neoplasm in a patient with an abdominal pacemaker.  Cardiol J. 2009;  16(3) 264-268
    PubMedGoogle Scholar
  • 49 Dodd III G D, Napier D, Schoolfield J D, Hubbard L. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome.  AJR Am J Roentgenol. 2005;  185(1) 51-57
    CrossrefPubMedGoogle Scholar
  • 50 Dupuy D E, Mayo-Smith W W, Abbott G F, DiPetrillo T. Clinical applications of radio-frequency tumor ablation in the thorax.  Radiographics. 2002;  22 S259-S269
    CrossrefPubMedGoogle Scholar
  • 51 Dupuy D E, Zagoria R J, Akerley W, Mayo-Smith W W, Kavanagh P V, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung.  AJR Am J Roentgenol. 2000;  174(1) 57-59
    PubMedGoogle Scholar
  • 52 Rose S C, Thistlethwaite P A, Sewell P E, Vance R B. Lung cancer and radiofrequency ablation.  J Vasc Interv Radiol. 2006;  17(6) 927-951, quiz 951
    CrossrefPubMedGoogle Scholar
  • 53 Fernando H C. Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases.  Ann Thorac Surg. 2008;  85(2) S780-S784
    CrossrefPubMedGoogle Scholar
  • 54 Steinke K, King J, Glenn D W, Morris D L. Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: tips from preliminary experience.  AJR Am J Roentgenol. 2004;  183(3) 605-611
    PubMedGoogle Scholar
  • 55 Simon C J, Dupuy D E, DiPetrillo T A et al.. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.  Radiology. 2007;  243(1) 268-275
    CrossrefPubMedGoogle Scholar
  • 56 Sano Y, Kanazawa S, Gobara H et al.. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience.  Cancer. 2007;  109(7) 1397-1405
    CrossrefPubMedGoogle Scholar
  • 57 Nomura M, Yamakado K, Nomoto Y et al.. Complications after lung radiofrequency ablation: risk factors for lung inflammation.  Br J Radiol. 2008;  81(963) 244-249
    CrossrefPubMedGoogle Scholar
  • 58 Yamakado K, Hase S, Matsuoka T et al.. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.  J Vasc Interv Radiol. 2007;  18(3) 393-398
    CrossrefPubMedGoogle Scholar
  • 59 Steinke K, Sewell P E, Dupuy D et al.. Pulmonary radiofrequency ablation—an international study survey.  Anticancer Res. 2004;  24(1) 339-343
    PubMedGoogle Scholar
  • 60 Steinke K, King J, Glenn D, Morris D L. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma.  J Comput Assist Tomogr. 2003;  27(5) 750-757
    CrossrefPubMedGoogle Scholar
  • 61 Gillams A R, Lees W R. Radiofrequency ablation of lung metastases: factors influencing success.  Eur Radiol. 2008;  18(4) 672-677
    CrossrefPubMedGoogle Scholar
  • 62 Hiraki T, Gobara H, Iishi T et al.. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.  J Thorac Cardiovasc Surg. 2007;  134(5) 1306-1312
    CrossrefPubMedGoogle Scholar
  • 63 Jin G Y, Han Y M, Lee Y S, Lee Y C. Radiofrequency ablation using a monopolar wet electrode for the treatment of inoperable non-small cell lung cancer: a preliminary report.  Korean J Radiol. 2008;  9(2) 140-147
    CrossrefPubMedGoogle Scholar
  • 64 Lee J M, Jin G Y, Goldberg S N et al.. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.  Radiology. 2004;  230(1) 125-134
    CrossrefPubMedGoogle Scholar
  • 65 Akeboshi M, Yamakado K, Nakatsuka A et al.. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.  J Vasc Interv Radiol. 2004;  15(5) 463-470
    CrossrefPubMedGoogle Scholar
  • 66 Hiraki T, Gobara H, Iishi T et al.. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients.  J Vasc Interv Radiol. 2007;  18(10) 1264-1269
    CrossrefPubMedGoogle Scholar
  • 67 Herrera L J, Fernando H C, Perry Y et al.. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates.  J Thorac Cardiovasc Surg. 2003;  125(4) 929-937
    CrossrefPubMedGoogle Scholar
  • 68 Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms.  J Vasc Interv Radiol. 2006;  17(10) 1625-1629
    CrossrefPubMedGoogle Scholar
  • 69 Yamakado K, Akeboshi M, Nakatsuka A et al.. Tumor seeding following lung radiofrequency ablation: a case report.  Cardiovasc Intervent Radiol. 2005;  28(4) 530-532
    CrossrefPubMedGoogle Scholar
  • 70 Hiraki T, Mimura H, Gobara H et al.. Two cases of needle-tract seeding after percutaneous radiofrequency ablation for lung cancer.  J Vasc Interv Radiol. 2009;  20(3) 415-418
    CrossrefPubMedGoogle Scholar
  • 71 Vaughn C, Mychaskiw II G, Sewell P. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm.  Anesth Analg. 2002;  94(5) 1149-1151
    CrossrefPubMedGoogle Scholar
  • 72 Sakurai J, Hiraki T, Mukai T et al.. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors.  J Vasc Interv Radiol. 2007;  18(1 Pt 1) 141-145
    CrossrefPubMedGoogle Scholar
  • 73 Gobara H, Hiraki T, Mukai T et al.. Abstract No. 330: Thermal nerve injury after percutaneous radiofrequency ablation for lung tumor.  J Vasc Interv Radiol. 2008;  19 S121-S122
    PubMedGoogle Scholar
  • 74 Le T X, Andrews R T. Thermal osteonecrosis of the rib after radiofrequency ablation in the thorax.  J Vasc Interv Radiol. 2008;  19(6) 940-944
    CrossrefPubMedGoogle Scholar
  • 75 Aberle D R, Gamsu G, Golden J A. Fatal systemic arterial air embolism following lung needle aspiration.  Radiology. 1987;  165(2) 351-353
    PubMedGoogle Scholar
  • 76 Yamamoto A, Matsuoka T, Toyoshima M et al.. Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted imaging.  AJR Am J Roentgenol. 2004;  183(6) 1785-1789
    CrossrefPubMedGoogle Scholar
  • 77 Rose S C, Fotoohi M, Levin D L, Harrell J H. Cerebral microembolization during radiofrequency ablation of lung malignancies.  J Vasc Interv Radiol. 2002;  13(10) 1051-1054
    CrossrefPubMedGoogle Scholar
  • 78 Jin G Y, Lee J M, Lee Y C, Han Y M. Acute cerebral infarction after radiofrequency ablation of an atypical carcinoid pulmonary tumor.  AJR Am J Roentgenol. 2004;  182(4) 990-992
    CrossrefPubMedGoogle Scholar
  • 79 Ghaye B, Bruyère P J, Dondelinger R F. Nonfatal systemic air embolism during percutaneous radiofrequency ablation of a pulmonary metastasis.  AJR Am J Roentgenol. 2006;  187(3) W327-W328
    CrossrefPubMedGoogle Scholar
  • 80 Stone M J, Venkatesan A M, Locklin J, Pinto P, Linehan M, Wood B J. Radiofrequency ablation of renal tumors.  Tech Vasc Interv Radiol. 2007;  10(2) 132-139
    CrossrefPubMedGoogle Scholar
  • 81 Brown D B. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation.  J Vasc Interv Radiol. 2005;  16(5) 597-613
    PubMedGoogle Scholar
  • 82 Hui G C, Tuncali K, Tatli S, Morrison P R, Silverman S G. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates.  J Vasc Interv Radiol. 2008;  19(9) 1311-1320
    CrossrefPubMedGoogle Scholar
  • 83 Zagoria R J, Traver M A, Werle D M, Perini M, Hayasaka S, Clark P E. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.  AJR Am J Roentgenol. 2007;  189(2) 429-436
    CrossrefPubMedGoogle Scholar
  • 84 Zagoria R J. Imaging-guided radiofrequency ablation of renal masses.  Radiographics. 2004;  24(Suppl 1) S59-S71
    CrossrefPubMedGoogle Scholar
  • 85 Farrell M A, Charboneau W J, DiMarco D S et al.. Imaging-guided radiofrequency ablation of solid renal tumors.  AJR Am J Roentgenol. 2003;  180(6) 1509-1513
    CrossrefPubMedGoogle Scholar
  • 86 Hwang J J, Walther M M, Pautler S E et al.. Radio frequency ablation of small renal tumors: intermediate results.  J Urol. 2004;  171(5) 1814-1818
    CrossrefPubMedGoogle Scholar
  • 87 Mayo-Smith W W, Dupuy D E, Parikh P M, Pezzullo J A, Cronan J J. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.  AJR Am J Roentgenol. 2003;  180(6) 1503-1508
    CrossrefPubMedGoogle Scholar
  • 88 Mahnken A H, Günther R W, Tacke J. Radiofrequency ablation of renal tumors.  Eur Radiol. 2004;  14(8) 1449-1455
    PubMedGoogle Scholar
  • 89 Gervais D A, McGovern F J, Arellano R S, McDougal W S, Mueller P R. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.  AJR Am J Roentgenol. 2005;  185(1) 64-71
    CrossrefPubMedGoogle Scholar
  • 90 Breen D J, Rutherford E E, Stedman B et al.. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors.  Cardiovasc Intervent Radiol. 2007;  30(5) 936-942
    CrossrefPubMedGoogle Scholar
  • 91 Dib R E, Touma N J, Kapoor A. Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses.  Can Urol Assoc J. 2009;  3(2) 143-149
    PubMedGoogle Scholar
  • 92 Ahrar K, Matin S, Wood C G et al.. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.  J Vasc Interv Radiol. 2005;  16(5) 679-688
    CrossrefPubMedGoogle Scholar
  • 93 Clark T W, Malkowicz B, Stavropoulos S W et al.. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.  J Vasc Interv Radiol. 2006;  17(3) 513-519
    CrossrefPubMedGoogle Scholar
  • 94 Park B K, Kim C K, Moo H L. Arteriovenous fistula after radiofrequency ablation of a renal tumor located within the renal sinus.  J Vasc Interv Radiol. 2007;  18(9) 1183-1185
    CrossrefPubMedGoogle Scholar
  • 95 Wah T M, Irving H C. Infectious complications after percutaneous radiofrequency ablation of renal cell carcinoma in patients with ileal conduit.  J Vasc Interv Radiol. 2008;  19(9) 1382-1385
    CrossrefPubMedGoogle Scholar
  • 96 Krambeck A E, Farrell M A, Charboneau J W, Frank I, Zincke H. Intraperitoneal drop metastasis after radiofrequency ablation of pararenal tumor recurrences.  Urology. 2005;  65(4) 797
    PubMedGoogle Scholar

Kent T SatoM.D. 

Department of Radiology, Northwestern University

251 East Huron Street, Chicago, IL 60611

Email: k-sato@northwestern.edu

      >